FAIRJOURNEY BIOLOGICS

fairjourney-biologics-logo

FairJourney Biologics, a fee-for-service company, was founded in 2012 and has been profitable since 2013. The fast growth coupled to financial independence is a market validation of the excellence in antibody discovery and engineering and a guarantee of stable and strong partnerships.

#People #Financial #More

FAIRJOURNEY BIOLOGICS

Social Links:

Industry:
Biotechnology

Founded:
2012-01-01

Status:
Active

Contact:
+351 222 437 510

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Global Site Tag Euro


Current Employees Featured

maria-pajuelo_image

Maria Pajuelo
Maria Pajuelo Co-founder & Chief Scientific Officer @ Fairjourney Biologics
Co-founder & Chief Scientific Officer
2012-05-01

teresa-barata_image

Teresa Barata
Teresa Barata Head of Protein Science Division @ Fairjourney Biologics
Head of Protein Science Division
2021-06-01

antónio-parada_image

António Parada
António Parada CEO & Co-founder @ Fairjourney Biologics
CEO & Co-founder
2012-05-01

Founder


antónio-parada_image

António Parada

maria-pajuelo_image

Maria Pajuelo

Investors List

gho-capital_image

GHO Capital

GHO Capital investment in Venture Round - Fairjourney Biologics

Investments List

Date Company Article Money raised
2022-03-08 Flow Eighteen38 Fairjourney Biologics investment in Corporate Round - Flow Eighteen38 5 M EUR

More informations about "Fairjourney Biologics"

Investment Case Study: FairJourney Biologics - Partners Group

FairJourney Biologics is a leading antibody discovery Contract Research Organization . Vertical. Health & Life. Entry. 2024. Location. Porto, Portugal. Website. View. Founded in 2012 and …See details»

FairJourney Biologics | About us

FairJourney Biologics has been a valuable CRO to Paragon Therapeutics since foundation. In addition to their renowned expertise in discovery and engineering of antibodies, their …See details»

Swiss buyout firm Partners Group lands deal for stake …

Jun 30, 2024 Swiss buyout fund Partners Group has bought a majority stake in FairJourney Biologics, a biotechnology company that has helped to discover novel antibody treatments for drugmakers including ...See details»

- Partners Group

Jul 1, 2024 Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization Baar-Zug, Switzerland; 1 July 2024 FairJourney is …See details»

FairJourney Biologics - Lab Manager

Jun 16, 2021 FairJourney Biologics is a leading biologics CRO, providing integrated services across antibody discovery, engineering, and production to global biopharma. Founded in 2012 …See details»

Partners Group to acquire majority stake in FairJourney Biologics, a ...

Jul 1, 2024 Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization 01.07.2024 / 08:00 CET/CEST Baar-Zug, …See details»

Fairjourney Biologics - Crunchbase Investor Profile

Biologics is a leading end-to-end solutions provider that specializes in cutting-edge antibody discovery and development. With over a decade of extensive expertise, the company leverages top-tier technologies and a team of …See details»

Fairjourney Biologics 2025 Company Profile: Valuation, …

Fairjourney Biologics was founded in 2012. Where is Fairjourney Biologics headquartered? Fairjourney Biologics is headquartered in Porto, Portugal. What is the size of Fairjourney Biologics? Fairjourney Biologics has 250 total …See details»

About FairJourney Biologics | Your Antibody Partner

Learn about FairJourney Biologics, a global leader in antibody discovery and biotechnological innovation. Explore our mission, and cutting-edge technologies driving scientific advancements.See details»

Partners Group acquires FairJourney Biologics

Jul 19, 2024 Cuatrecasas advised Partners Group, a leading global private markets firm acting on behalf of its clients, on acquiring a majority stake in FairJourney Biologics from GHO Capital Partners.. Founded in 2012 and …See details»

FairJourney Biologics - 2025 Company Profile - Tracxn

Mar 8, 2025 FairJourney Biologics - Provider of end to end antibody development services. Acquired by Partners Group. Founded by Antonio Parada in the year 2012. FairJourney …See details»

The Antibody Series - FairJourney Biologics

The Antibody Series has quickly become the fastest growing antibody conference of its kind and a must attend event for antibody experts. The Antibody Series brings together experts across …See details»

FairJourney Biologics - The Org

FairJourney Biologics is a privately established company with an outstanding track record of biotech and biopharmaceutical partners (Merus, argenX, BMS, Bayer, among others), offering …See details»

GHO Capital realises significant return with sale of FairJourney …

Jul 1, 2024 Under GHO’s ownership FairJourney Biologics has become an established leader in antibody discovery and development, with more than 5x revenue growth since 2019. GHO to …See details»

Ropes & Gray Advises Partners Group on Investment in …

Jul 1, 2024 Ropes & Gray has advised Partners Group, one of the largest firms in the global private markets industry, on its acquisition – on behalf of its clients – of a majority stake in …See details»

FairJourney Biologics Establishes Supervisory Board - BioSpace

2 days ago PORTO, Portugal--(BUSINESS WIRE)--FairJourney Biologics S.A., global leader in antibody discovery and development, today announced the formation of its Supervisory Board …See details»

FairJourney Biologics Establishes Supervisory Board - Yahoo Finance

2 days ago PORTO, Portugal, March 25, 2025--FairJourney Biologics S.A., global leader in antibody discovery and development, today announced the formation of its Supervisory Board …See details»

INFORS HT partners with FairJourney Biologics to deliver …

Nov 27, 2023 Hence we are thrilled to share the success story of FairJourney Biologics, an innovative Contract Research Organization specialized in Antibody Discovery and Production. …See details»

FairJourney Biologics Establishes Supervisory Board

2 days ago António Parada, CEO, FairJourney Biologics, said: “Our new board marks an exciting chapter for FairJourney Biologics. With leaders of such exceptional caliber and …See details»

FairJourney Biologics: 2024 Milestones & 2025 Vision - fjbio.com

Jan 21, 2025 Explore FairJourney Biologics' 2024 highlights: new labs, B-cell tech, The Antibody Series success, and 2025 plans for global leadership in antibody discovery.See details»

linkstock.net © 2022. All rights reserved